Hemodiafiltración intermitente en línea como terapia de reemplazo renal en paciente crítico: experiencia en un centro de diálisis de agudo

Simple item page
dc.catalogadoryvc
dc.contributor.authorBarrios Araya, Silvia
dc.contributor.authorEspinoza Coya, María Elisa
dc.contributor.authorNuñez Gómez, Kelly
dc.contributor.authorSepúlveda Palamara, Rodrigo
dc.contributor.authorMolina Muñoz, Yerko
dc.date.accessioned2024-03-27T13:32:06Z
dc.date.available2024-03-27T13:32:06Z
dc.date.issued2019
dc.description.abstractBackground: In critical patients with acute renal failure, intermittent diffusive renal replacement techniques cause hemodynamic problems due to their high depurative efficiency. This situation is avoided using continuous low efficiency therapies, which are expensive, prevent patient mobilization and add hemorrhagic risk due to systemic anticoagulation. Intermittent and prolonged hemodiafiltration (HDF) has the depurative benefits of diffusion, plus the positive attributes of convection in a less expensive therapy. Aim: To report our experience with intermittent and prolonged on-line HDF in critically ill patients. Patients and Methods: During 2016, HDF therapies performed on critical patients with indication of renal replacement therapy were characterized. The hemodynamic profile was evaluated (doses of noradrenaline, blood pressure, heart rate and perfusion parameters). Results: Fifty-one therapies were performed in 25 critical patients, aged 58 ± 11 years (28% women), with an APACHE II score of 22.1 ±10. The average time of the therapies was 4.15 hours (range 3-8 hours), the replacement volume was 75 ± 18 mL/kg/h and ultrafiltration rate was 226 ± 207 mL/h. The mean initial, maximum and final noradrenaline doses were 0.07 ± 0.1, 0.13 ±0.18 and 0.09 ±0.16 μg/kg/min respectively. No differences between patients with low, medium and high doses of noradrenaline or dose increases during therapy, were observed. The greatest decrease in mean arterial pressure was 15.3% and the maximum increase in heart rate was 12.8%. Anticoagulation was not required in 88% of therapies. Conclusions: High-volume intermittent or prolonged HDF is an effective therapy in critical patients, with good hemodynamic tolerability, lower costs and avoidance of systemic anticoagulation risks.
dc.fechaingreso.objetodigital2024-04-06
dc.fuente.origenORCID
dc.identifier.doi10.4067/s0034-98872019000400409
dc.identifier.urihttp://dx.doi.org/10.4067/s0034-98872019000400409
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/84789
dc.information.autorucEscuela de enfermería ; Barrios Araya, Silvia ; 0000-0003-2081-3693 ; 144076
dc.information.autorucEscuela de enfermería ; Espinoza Coya, María Elisa ; S/I ; 68359
dc.information.autorucEscuela de enfermería ; Sepúlveda Palamara, Rodrigo ; S/I ; 252768
dc.information.autorucEscuela de enfermería ; Molina Muñoz, Yerko ; S/I ; 119453
dc.issue.numero4
dc.language.isoes
dc.nota.accesocontenido completo
dc.pagina.final415
dc.pagina.inicio409
dc.revistaRevista Médica de Chile
dc.rightsacceso abierto
dc.subjectAcute kidney injury
dc.subjectCritically Ill
dc.subjectHemodiafiltration
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.titleHemodiafiltración intermitente en línea como terapia de reemplazo renal en paciente crítico: experiencia en un centro de diálisis de agudo
dc.title.alternativeExperience with inline intermittent hemodiafiltration as renal replacement therapy in critically ill patients
dc.typeartículo
sipa.codpersvinculados144076
sipa.codpersvinculados68359
sipa.codpersvinculados252768
sipa.codpersvinculados119453
sipa.trazabilidadORCID;2024-03-25
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Hemodiafiltración intermitente.pdf
Size:
163.38 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas